The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.
Essential Responsibilities
Education & Experience
Preferred Education and Experience:
Physical and Travel Requirements:
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including:
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com .
...confidence and ease . Were headquartered in NYC and offer hybrid NY-based positions (Four days/ week in-office). About the role The Broker-Dealer Operations Team at Betterment oversees and operates Betterments broker-dealer entity that safeguards over $65B in assets...
...Business Development Manager Plastics/Injection Molding (Remote, Detroit Preferred) Base: $120,000$125,000 + $3040K Commission | OTE $150K$160K+ | Full Benefits Are you a driven sales/account management professional with experience in plastics or injection molding...
...Clarios is the force behind the world's most recognizable car battery brands, powering vehicles from leading automakers like Ford, General Motors, Toyota, Honda, and Nissan. With 18,000 employees worldwide, we develop, manufacture, and distribute energy storage solutions...
...Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX). Job Description Effectively run plastic injection molding machines within safety and quality standards To be able to work safety and follow all safety guidelines. Able to work a...
...Overview AML Sr. Investigator III Title: AML Senior Investigator III/ AML Sr. Supervisor Level: Principal Associate Job Description: The Anti-Money Laundering (AML) Senior Supervisor supervises various AML processes, which might include suspicious activity...